5 Telehealth Legal Issues to Watch in 2022

31
5

The rapid shift to reliance on digital healthcare technologies has successfully produced convenient ways to diagnose and treat patients. However, that shift comes with its share of telehealth legal issues that clinicians and practitioners must address. This article will explore the current climate of digital health regulation to inform providers of critical issues to move forward with the necessary awareness. 

The telehealth boom called for creating a variety of temporary waivers, executive orders, and regulations that would apply in the medical field. However, there is still uncertainty concerning licensure and reimbursement. Now that many of these temporary rules are set to expire, clinicians and practitioners are keenly interested in digital health regulation and the doors that will open or close moving forward.

For example, the Centers for Medicare & Medicaid Services (CMS) Medical Physician Fee Schedule Final Rule of 2022 made specific temporary measures permanent. However, there is no guidance regarding the Ryan Haight Act, which involves controlled substances prescribed via telehealth without an in-person examination. See TBHI’s previous article Telehealth Opioids, and Ryan Haight Act Update, for more information. There have also been changes on the state level regarding telehealth delivery. Specifically, many states have removed restrictions concerning digital communication methods like email, phone, texts, etc.

FDA

Companies that develop medical software devices should know the FDA’s digital health regulation actions. The FDA has been publishing multiple resources clarifying its expectations regarding medical software development.

Although the FDA is still developing these resources, software creators can proactively determine expectations by engaging in FDA premarket submissions. The FDA is also expected to finalize its guidance resources on Clinical Decision Support software before the end of the year. This software helps clinicians and practitioners educate patients on their healthcare options. Once the guidelines are released, developers will better understand the FDA’s expectations.

Privacy and Cybersecurity

Privacy and cybersecurity are other important telehealth legal issues. During the COVID health crisis, there were several instances where individuals attempted to apply HIPAA laws to protect information outside of its scope. While the Office for Civil Rights (OCR) guided the operation of drive-through test and vaccination sites and telehealth protocol, some medical professionals took the legislation to apply to cybersecurity issues. This has caused many clinicians and practitioners to apply HIPAA as a best practice, whether it is integral to their business model or not. While this may seem admirable, it can result in false claims under federal and state laws.

As a result, companies that fall outside the OCR jurisdiction will be scrutinized. They will be examined closely regarding how they share private information and whether they have insurance to protect them from cybersecurity attacks. See TBHI’s previous articles related to HIPAA and cybersecurity below.

Fraud and Abuse

During the pandemic, the increase in digital healthcare created the need for temporary waivers and flexibilities. However, the response to these temporary actions is not entirely positive. For example, the HHS Office of the General Inspector (OIG) issued a policy statement making clinicians and practitioners aware of new cost-sharing obligations incurred for telehealth services consistent with appropriate coverage and payment rules put in action during the pandemic. And while the OIG sees the benefits of telehealth, they are currently reviewing it, particularly regarding Medicare and Medicaid requirements for documenting and billing home health services. See TBHI’s articleTelehealth Home Health for more information.

There have also been various fraud and abuse telehealth legal issues that have appeared during the pandemic. One major incident was Operation Rubber Stamp which occurred in October of 2020. In this case, the Department of Justice investigated 345 practitioners and clinicians across 51 federal states for fraudulent medical activity. The activity resulted in the revocation of Medicare billing privileges for over 250 medical professionals. This fraudulent activity has resulted in strict digital health regulation, including ongoing audits and systems examinations that may result in high costs and patient harm.

The new digital healthcare climate has produced an atmosphere of antitrust. With two heavily targeted industries coming together, healthcare and technology, the Federal Trade Commission (FTC) will be devoting more of its resources to investigating clinicians and practitioners in the digital healthcare field. The Department of Justice is also doing its part to keep an eye on the industry. The organizations are focusing on a corporate crisis in America that may be detrimental to competition. As a result, digital healthcare companies should be paying close attention to how they handle joint ventures, even if those transactions don’t affect their competition.

Basic Telehealth Legal Issues: Rules, Regulations & Risk Management

Bring your telehealth practice into legal compliance. Get up to date on inter-jurisdictional practice, privacy, HIPAA, referrals, risk management, duty to warn, the duty to report, termination, and much more!

Disclaimer: The Telebehavioral Health Institute (TBHI Telehealth.org) offers information as educational material designed to inform you of issues, products, or services potentially of interest. We cannot and do not accept liability for your decisions regarding any information offered. Please conduct your due diligence before taking action. Also, the views and opinions expressed are not intended to malign any organization, company, or individual. Product names, logos, brands, and other trademarks or images are the property of their respective trademark holders. There is no affiliation, sponsorship, or partnership suggested by using these brands unless contained in an ad. We do not and cannot offer legal, ethical, billing technical, medical, or therapeutic advice. Use of this site constitutes your agreement to TBHI Privacy Policy and Terms and Conditions.

Subscribe
Notify of
guest
5 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
Gayle Logan
Gayle Logan
5 months ago

Please correct there is no editing ability. I request clients to review and authorize The Release of Information, Consent/ Disclosure, and the Limitations of Confidentiality Forms.

Amy Hill
Amy Hill
5 months ago

What is the current thinking about telehealth sessions being recorded? I have a client going through a divorce and opposing counsel has subpoenaed records from her medical doctors and has specifically asked for video and audio recordings from her telehealth sessions. She does not recall giving consent for her appointments to be recorded. I seem to recall when I went through my training with TBHI that we were taught not to record telehealth appointments but to keep notes just as we would an in-office appointment. Has this changed? Can you comment on this?

Gayle Logan
Gayle Logan
5 months ago

I understand that HIPPA’compliance and regulations apply. I have the clients review disclosure and consent form, limitations of confidentiality Form.

ERNST CHRISTIAN GAUDERER
ERNST CHRISTIAN GAUDERER
6 months ago

Can I deliver Telehealthcare from overseas?
I have delivered TelePsychiatric care for the State of Michigan for its Department of Corrections, for the last 10 years.
Occasionally I delivered care from overseas.
A few months ago, telecare from overseas was banned.
Please comment.
Thanks.
Ernst Gauderer, MD.

5
0
Would love your thoughts, please comment.x